
发表一篇学和医学成像类SCI论文
需要多少钱?
Abstract:
:Background The management of potential pre-eclamptic patients using the soluble FMS-like tyrosine kinase 1 (sFlt-1)/ placental growth factor (PlGF) ratio is characterised by frequent false-positive results. Methods A retrospective cohort study was conducted to identify and validate cut-off values, obtained using a machine learning model, for the sFlt-1/PlGF ratio and NT-proBNP that would be predictive of the absence or presence of early-onset pre-eclampsia (PE) in singleton pregnancies presenting at 24 to 33 + 6 weeks of gestation. Results For the development cohort, we defined two sFlt-1/PlGF ratio cut-off values of 23 and 45 to rule out and rule in early-onset PE at any time between 24 and 33 + 6 weeks of gestation. Using an sFlt-1/PlGF ratio cut-off value of 23, the negative predictive value (NPV) for the development of early-onset PE was 100% (95% confidence interval [CI]: 99.5-100). The positive predictive value (PPV) of an sFlt-1/PlGF ratio >45 for a diagnosis of early-onset PE was 49.5% (95% CI: 45.8-55.6). When an NT-proBNP value >174 was combined with an sFlt-1/PlGF ratio >45, the PPV was 86% (95% CI: 79.2-92.6). In the validation cohort, the negative and positive values were very similar to those found for the development cohort. Conclusions An sFlt-1/PlGF ratio <23 rules out early-onset PE between 24 and 33 + 6 weeks of gestation at any time, with an NPV of 100%. An sFlt-1/PlGF ratio >45 with an NT-proBNP value >174 significantly enhances the probability of developing early-onset PE.
展开更多
最新影响因子:8.49 | 期刊ISSN:1434-6621 | CiteScore:2.34 |
出版周期:Monthly | 是否OA:YES | 出版年份:1998 |
自引率:15.70% | 研究方向:医学-医学实验技术 |
出版地区:GERMANY |
SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)
专业编辑在线一对一答疑及时解决您的问题
CCLM is an official journal of the Belgian Society of Clinical Chemistry (BVKC/SBCC), the German United Society of Clinical Chemistry and Laboratory Medicine (DGKL), Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC), and the Slovenian Association for Clinical Chemistry. CCLM keeps you up-to-date with the latest developments in the clinical laboratory sciences. It reports on progress in fundamental and applied research. Areas covered include: clinical biochemistry, molecular medicine, hematology, immunology, microbiology, virology, drug measurement, genetic epidemiology, evaluation of diagnostic markers, new reagents and systems, reference materials, and reference values. CCLM further promotes communication concerning these topics by the publication of news, letters and meeting reports. New teaching and training methods applicable to laboratory medicine are also covered.
CCLM是比利时临床化学学会(BVKC/SBCC)、德国临床化学与实验医学联合学会(DGKL)、意大利临床生物化学与临床分子生物学学会(SIBioC)和斯洛文尼亚临床化学协会的官方期刊。CCLM让您随时了解临床实验室科学的最新发展。报告基础研究和应用研究的进展。涵盖的领域包括:临床生物化学、分子医学、血液学、免疫学、微生物学、病毒学、药物测量、遗传流行病学、诊断标记的评估、新试剂和系统、参考材料和参考价值。CCLM还通过出版新闻、信函和会议报告进一步促进有关这些主题的交流。还介绍了适用于检验医学的新的教学和培训方法。
大类(学科) | 小类(学科) | 学科排名 |
医学 |
MEDICAL LABORATORY TECHNOLOGY (医学实验技术) 2区 |
7/30 |
年度总发文量 | 年度论文发表量 | 年度综述发表量 |
226 | 191 | 35 |
引文计数(2018)
文献(2015-2017)
2354次引用
1007篇文献
序号 | 类别 | 排名 | 百分位 |
1 |
大类(学科):Biochemistry, Genetics and Molecular Biology
小类(学科):Clinical Biochemistry
|
#53/118
点击查看排名表
|
|
2 |
大类(学科):Medicine
小类(学科):Biochemistry (medical)
|
#16/50
点击查看排名表
|
|
推荐刊物均可到国家新闻出
版总署网站查询正刊
可签署保密协议 ,不透露任
何用户信息可跟踪进程,全程
协议
1对1服务,7x24小时在线
14年经验沉淀,实体公司
运营
liting7111
研究方向:biomarker
审稿时间: 3个月内 接受率: 一般容易(75%命中)
liting7111
liting7111
liting7111
研究方向:实验室质量控制 PCR实验室
liting7111
接受率: 比较困难(25%命中)
liting7111
liting7111
研究方向:心血管
接受率: 中等(50%命中)
liting7111
liting7111
liting7111
研究方向:biomarker
审稿时间: 2个月内
liting7111
研究方向:实验室质量控制
liting7111
liting7111
liting7111
接受率: 一般容易(75%命中)
liting7111
liting7111
liting7111
研究方向:实验室检测
审稿时间: 2个月内 接受率: 比较困难(25%命中)
影响因子:5.315
ISSN:0148-396X
研究方向:医学-临床神经学
影响因子:1.725
ISSN:0028-3770
研究方向:医学-临床神经学
影响因子:2.21
ISSN:1878-8750
研究方向:CLINICAL NEUROLOGY-SURGERY
影响因子:4.332
ISSN:1092-0684
研究方向:CLINICAL NEUROLOGY-SURGERY
影响因子:2.816
ISSN:0001-6268
研究方向:医学-临床神经学
影响因子:2.8
ISSN:0344-5607
研究方向:医学-临床神经学
影响因子:0.972
ISSN:1019-5149
研究方向:医学-临床神经学
影响因子:1.532
ISSN:0256-7040
研究方向:医学-临床神经学
影响因子:1.165
ISSN:1016-2291
研究方向:医学-临床神经学
CLINICAL CHEMISTRY AND LABORATORY MEDICINE 投稿经验
(由下方点评分析获得,17人参与,10175人阅读)